These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21962052)

  • 21. Predictive models of acute mountain sickness after rapid ascent to various altitudes.
    Beidleman BA; Tighiouart H; Schmid CH; Fulco CS; Muza SR
    Med Sci Sports Exerc; 2013 Apr; 45(4):792-800. PubMed ID: 23135373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residence at Moderate Versus Low Altitude Is Effective at Maintaining Higher Oxygen Saturation During Exercise and Reducing Acute Mountain Sickness Following Fast Ascent to 4559 m.
    Bernardi E; Pomidori L; Cavallari D; Mandolesi G; Cogo A
    Wilderness Environ Med; 2017 Jun; 28(2):122-126. PubMed ID: 28455198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and time course of acute mountain sickness in older children and adolescents after rapid ascent to 3450 meters.
    Bloch J; Duplain H; Rimoldi SF; Stuber T; Kriemler S; Allemann Y; Sartori C; Scherrer U
    Pediatrics; 2009 Jan; 123(1):1-5. PubMed ID: 19117853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oximetry fails to predict acute mountain sickness or summit success during a rapid ascent to 5640 meters.
    Wagner DR; Knott JR; Fry JP
    Wilderness Environ Med; 2012 Jun; 23(2):114-21. PubMed ID: 22656656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya.
    Vardy J; Vardy J; Judge K
    Aviat Space Environ Med; 2006 Jul; 77(7):742-4. PubMed ID: 16856361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness.
    Dorward DA; Thompson AA; Baillie JK; MacDougall M; Hirani N
    Respir Med; 2007 Mar; 101(3):587-94. PubMed ID: 16890420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxygen saturation course and altitude symptomatology during an expedition to broad peak (8047 m).
    Tannheimer M; Thomas A; Gerngross H
    Int J Sports Med; 2002 Jul; 23(5):329-35. PubMed ID: 12165883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention and therapy of altitude sickness].
    Maggiorini M
    Ther Umsch; 1993 Apr; 50(4):221-7. PubMed ID: 8378872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes of pulmonary diffusing capacity in subjects with acute mountain sickness].
    Chen Q; Ge R; Ruan Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Feb; 23(2):101-3. PubMed ID: 11778493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute Mountain Sickness is Reduced Following 2 Days of Staging During Subsequent Ascent to 4300 m.
    Beidleman BA; Fulco CS; Glickman EL; Cymerman A; Kenefick RW; Cadarette BS; Andrew SP; Staab JE; Sils IV; Muza SR
    High Alt Med Biol; 2018 Dec; 19(4):329-338. PubMed ID: 30517038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving sleep at altitude: a comparison of therapies.
    Rodway GW; Edsell ME; Wong B; Windsor JS;
    Wilderness Environ Med; 2011 Dec; 22(4):316-20. PubMed ID: 21982758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous iron supplementation may protect against acute mountain sickness: a randomized, double-blinded, placebo-controlled trial.
    Talbot NP; Smith TG; Privat C; Nickol AH; Rivera-Ch M; León-Velarde F; Dorrington KL; Robbins PA
    High Alt Med Biol; 2011; 12(3):265-9. PubMed ID: 21962070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mt. Whitney: determinants of summit success and acute mountain sickness.
    Wagner DR; D'Zatko K; Tatsugawa K; Murray K; Parker D; Streeper T; Willard K
    Med Sci Sports Exerc; 2008 Oct; 40(10):1820-7. PubMed ID: 18799993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptoms of acute mountain sickness in Sherpas exposed to extremely high altitude.
    Droma Y; Hanaoka M; Basnyat B; Arjyal A; Neupane P; Pandit A; Sharma D; Kubo K
    High Alt Med Biol; 2006; 7(4):312-4. PubMed ID: 17173517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Everest or bust: a cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas.
    Basnyat B; Lemaster J; Litch JA
    Aviat Space Environ Med; 1999 Sep; 70(9):867-73. PubMed ID: 10503751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sea-level physical activity and acute mountain sickness at moderate altitude.
    Honigman B; Read M; Lezotte D; Roach RC
    West J Med; 1995 Aug; 163(2):117-21. PubMed ID: 7571557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altitude preexposure recommendations for inducing acclimatization.
    Muza SR; Beidleman BA; Fulco CS
    High Alt Med Biol; 2010; 11(2):87-92. PubMed ID: 20586592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amelioration of the symptoms of acute mountain sickness by staging and acetazolamide.
    Evans WO; Robinson SM; Horstman DH; Jackson RE; Weiskopf RB
    Aviat Space Environ Med; 1976 May; 47(5):512-6. PubMed ID: 1275841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in spirometric parameters and arterial oxygen saturation during a mountain ascent to over 3000 meters].
    Compte-Torrero L; Botella de Maglia J; de Diego-Damiá A; Gómez-Pérez L; Ramírez-Galleymore P; Perpiñá-Tordera M
    Arch Bronconeumol; 2005 Oct; 41(10):547-52. PubMed ID: 16266667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraocular pressure during a very high altitude climb.
    Bosch MM; Barthelmes D; Merz TM; Truffer F; Knecht PB; Petrig B; Bloch KE; Hefti U; Schubiger G; Landau K
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1609-13. PubMed ID: 19875651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.